PRF 10th Anniversary Workshop on Progeria - "From Bench to Bedside in a Decade"
PRF 10 周年早衰症研讨会 - “十年内从实验室到临床”
基本信息
- 批准号:7925396
- 负责人:
- 金额:$ 2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-04-01 至 2011-03-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAgeAgingAnimal ModelAnniversaryAtherosclerosisBiologyCardiovascular DiseasesCell AgingCell NucleusCellsChildClinicalClinical ResearchClinical TreatmentClinical TrialsCollaborationsCommunitiesDatabasesDiagnosticDiseaseEducationEducational workshopFlowersFosteringFoundationsFundingGenesHeart DiseasesHumanIndividualLaboratoriesLamin Type ALaminsLifeLightMedicalMembrane ProteinsMissionModelingMutationMyocardial InfarctionNatural HistoryNuclear EnvelopeParentsPremature aging syndromeProgeriaRare DiseasesRecording of previous eventsResearchRoleScienceScientistSeriesSignal TransductionSignaling MoleculeSourceStrokeSyndromeSystemTestingTissue BankingTissue BanksUnited States National Institutes of HealthUpdateVascular Diseasesage relatedaging populationbasebench to bedsidefarnesylationgene discoveryhigh throughput screeninginduced pluripotent stem cellinhibitor/antagonistmeetingsmouse modelnormal agingpatient registrypostersprogramspublic health relevancetranslational medicinetreatment trial
项目摘要
DESCRIPTION (provided by applicant):
Hutchinson-Gilford progeria syndrome (Progeria or HGPS) is a rare, autosomal dominant segmental premature-aging disease in which 100% of children die at an average age of thirteen years due to strokes or heart attacks, a consequence of prolonged atherosclerosis. It is caused by a mutation in the LMNA gene, which encodes lamin A, an inner nuclear membrane protein that serves as a key structural and cell signaling molecule. Importantly, the abnormal lamin A (called progerin), is also produced by normal individuals at low levels and builds up in nuclei with increasing age. Roles for lamin A and progerin in the heart disease and aging that affect us all have come to light only in the wake of the Progeria gene discovery. Hence, the study of this rare disease has provided a new avenue for the study of cellular aging and vascular disease in the normal aging population. The Progeria Research Foundation (PRF) was founded in 1999. Its mission is to discover the cause, treatment and cure for Progeria and its aging-related disorders, through research and education. An exciting effort for research into Progeria and its relationship to cardiovascular disease and aging has been developed through a series of 5 scientific workshops held in 2001, 2003, 2004, 2005 and 2007. These workshops have propelled the field from obscurity, through gene discovery, creation of Progeria mouse models, natural history studies, testing treatments in the laboratory, and initiation of first-ever treatment trials for children with Progeria. This 2.5 day meeting will begin with a special panel discussion with parents and children living with Progeria. This will be followed by two days of 25 formal presentations, 40-50 poster presentations, and an informal evening meeting session. Experts in the fields of aging, heart disease, lamin biology, and Progeria, as well as experts on cutting edge research such as induced pluripotent stem cells and high throughput assay systems, will contribute to the workshop from both the basic and clinical perspectives. A highlight of the 2010 workshop will be the discussion of farnesylation inhibitors as treatment for Progeria animal models and in humans, including presentation of results from the first completed HGPS clinical trial. We will provide an open forum for discussing essential directions for Progeria research, fostering collaborative scientific efforts, discussing specific funding needs for the field from sources such as PRF and NIH, and providing updates on infrastructural programs that aid the scientific and medical communities such as the Progeria patient registry, cell and tissue bank, clinical and research database, and diagnostics facility. The recent history of Progeria research is a model for translational medicine. Years of basic study into lamin A has allowed the field to blossom with promise, as the biologically based treatment trials for Progeria ensue. The 2010 Workshop will bring basic and clinical scientists together once again, to plan the coming years of discovery into Progeria, lamin biology, heart disease, and cellular aging. PUBLIC HEALTH RELEVANCE: Scientific workshops on Hutchinson Gilford Progeria Syndrome (Progeria) and related Progerias, co-sponsored by PRF and NIH, have been key in developing the Progeria research agenda over the past 8 years. Cutting edge research since the last Workshop in 2007 has confirmed and strengthened Progeria as a unique model for investigating many aspects of heart disease in the normal aging population. The 2010 workshop will unveil results from the first-ever clinical treatment trial for children with Progeria, and will continue to foster collaborations between basic and clinical research scientists in an effort to bring bench science to the bedside for progeria, and for the general aging population.
描述(由申请人提供):
Hutchinson-Gilford早老综合征(Hutchinson-Gilford progeria syndrome,HGPS)是一种罕见的常染色体显性遗传节段性早衰症,其中100%的儿童死于中风或心脏病发作,平均年龄为13岁,这是长期动脉粥样硬化的结果。它是由LMNA基因突变引起的,LMNA基因编码核纤层蛋白A,核纤层蛋白A是一种内核膜蛋白,是关键的结构和细胞信号分子。重要的是,异常核纤层蛋白A(称为早老蛋白)也由正常个体以低水平产生,并随着年龄的增长在细胞核中积累。核纤层蛋白A和早老蛋白在影响我们所有人的心脏病和衰老中的作用只是在早老症基因发现之后才被发现。因此,对这一罕见疾病的研究为正常老年人群的细胞衰老和血管疾病的研究提供了新的途径。 早老症研究基金会(PRF)成立于1999年。它的使命是通过研究和教育发现早衰症及其与衰老有关的疾病的原因、治疗和治愈。通过2001年、2003年、2004年、2005年和2007年举办的一系列5个科学讲习班,对早衰症及其与心血管疾病和衰老的关系进行了令人兴奋的研究。这些研讨会推动了该领域从默默无闻,通过基因发现,创建早衰症小鼠模型,自然史研究,在实验室中测试治疗,并启动有史以来第一次治疗试验与早衰症儿童。 这个为期2.5天的会议将开始与父母和患有早衰症的儿童进行特别小组讨论。随后将举行为期两天的25场正式演讲,40-50场海报演讲和一场非正式的晚间会议。衰老、心脏病、核纤层蛋白生物学和早衰症领域的专家,以及诱导多能干细胞和高通量检测系统等前沿研究的专家,将从基础和临床角度为研讨会做出贡献。2010年研讨会的一个亮点将是讨论法尼基化抑制剂作为治疗早衰症动物模型和人类,包括介绍第一个完成的HGPS临床试验的结果。我们将提供一个开放的论坛,讨论早衰症研究的基本方向,促进科学合作,讨论来自PRF和NIH等来源的该领域的具体资金需求,并提供有关基础设施计划的更新,以帮助科学和医学界,如早衰症患者登记处,细胞和组织库,临床和研究数据库,以及诊断设施。 早衰症研究的最新历史是转化医学的一个模型。对核纤层蛋白A多年的基础研究使该领域有希望开花,因为基于生物学的治疗早衰症的试验随之而来。2010年的研讨会将再次把基础和临床科学家聚集在一起,计划未来几年的发现到早衰症,核纤层蛋白生物学,心脏病和细胞衰老。公共卫生关系:由PRF和NIH共同主办的关于哈钦森吉尔福德早衰综合征(早衰症)和相关早衰症的科学讲习班在过去8年中一直是制定早衰症研究议程的关键。自2007年上一次研讨会以来的前沿研究已经证实并加强了早衰症作为研究正常老龄化人群心脏病许多方面的独特模型。2010年的研讨会将公布有史以来第一次对患有早衰症的儿童进行临床治疗试验的结果,并将继续促进基础和临床研究科学家之间的合作,努力将实验室科学带到早衰症的床边,并为一般老龄化人口服务。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LESLIE B GORDON其他文献
LESLIE B GORDON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LESLIE B GORDON', 18)}}的其他基金
The Progeria Research Foundation 8th International Scientific Workshop "Across the Table, Around the Globe"
早衰研究基金会第八届国际科学研讨会“跨越桌子,环游全球”
- 批准号:
9195040 - 财政年份:2016
- 资助金额:
$ 2万 - 项目类别:
PRF 11th Anniversary Workshop on Progeria - "Hand in Hand: Basic and Clinica
PRF 11 周年早衰症研讨会 - “手拉手:基础与临床
- 批准号:
8530081 - 财政年份:2013
- 资助金额:
$ 2万 - 项目类别:
The 2007 Progeria Research Foundation Workshop on Hutchinson Gilford Progeria
2007 年早衰症研究基金会哈钦森·吉尔福德早衰症研讨会
- 批准号:
7407834 - 财政年份:2007
- 资助金额:
$ 2万 - 项目类别:
The Progeria Research Foundation International Progeria Workshop
早衰症研究基金会国际早衰症研讨会
- 批准号:
7128295 - 财政年份:2006
- 资助金额:
$ 2万 - 项目类别:
Creating a Medical and Research Database for HGPS
为 HGPS 创建医学和研究数据库
- 批准号:
6596647 - 财政年份:2003
- 资助金额:
$ 2万 - 项目类别:
Creating a Medical and Research Database for HGPS
为 HGPS 创建医学和研究数据库
- 批准号:
6752067 - 财政年份:2003
- 资助金额:
$ 2万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The Phenomenon of Stem Cell Aging according to Methylation Estimates of Age After Hematopoietic Stem Cell Transplantation
根据造血干细胞移植后甲基化年龄估算干细胞衰老现象
- 批准号:
23K07844 - 财政年份:2023
- 资助金额:
$ 2万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of Age-dependent Functional Changes in Skeletal Muscle CB1 Receptors by an in Vitro Model of Aging-related Muscle Atrophy
通过衰老相关性肌肉萎缩的体外模型分析骨骼肌 CB1 受体的年龄依赖性功能变化
- 批准号:
22KJ2960 - 财政年份:2023
- 资助金额:
$ 2万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Joint U.S.-Japan Measures for Aging and Dementia Derived from the Prevention of Age-Related and Noise-induced Hearing Loss
美日针对预防与年龄相关和噪声引起的听力损失而导致的老龄化和痴呆症联合措施
- 批准号:
23KK0156 - 财政年份:2023
- 资助金额:
$ 2万 - 项目类别:
Fund for the Promotion of Joint International Research (International Collaborative Research)
The Effects of Muscle Fatigability on Gait Instability in Aging and Age-Related Falls Risk
肌肉疲劳对衰老步态不稳定性和年龄相关跌倒风险的影响
- 批准号:
10677409 - 财政年份:2023
- 资助金额:
$ 2万 - 项目类别:
Characterizing gut physiology by age, frailty, and sex: assessing the role of the aging gut in "inflamm-aging"
按年龄、虚弱和性别表征肠道生理学特征:评估衰老肠道在“炎症衰老”中的作用
- 批准号:
497927 - 财政年份:2023
- 资助金额:
$ 2万 - 项目类别:
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
- 批准号:
10679287 - 财政年份:2023
- 资助金额:
$ 2万 - 项目类别:
Role of AGE/RAGEsignaling as a driver of pathological aging in the brain
AGE/RAGE信号传导作为大脑病理性衰老驱动因素的作用
- 批准号:
10836835 - 财政年份:2023
- 资助金额:
$ 2万 - 项目类别:
Elucidation of the protein kinase NLK-mediated aging mechanisms and treatment of age-related diseases
阐明蛋白激酶NLK介导的衰老机制及年龄相关疾病的治疗
- 批准号:
23K06378 - 财政年份:2023
- 资助金额:
$ 2万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Underlying mechanisms of age-related changes in ingestive behaviors: From the perspective of the aging brain and deterioration of the gustatory system.
与年龄相关的摄入行为变化的潜在机制:从大脑老化和味觉系统退化的角度来看。
- 批准号:
23K10845 - 财政年份:2023
- 资助金额:
$ 2万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Targeting Age-Activated Proinflammatory Chemokine Signaling by CCL2/11 to Enhance Skeletal Muscle Regeneration in Aging
通过 CCL2/11 靶向年龄激活的促炎趋化因子信号传导以增强衰老过程中的骨骼肌再生
- 批准号:
478877 - 财政年份:2023
- 资助金额:
$ 2万 - 项目类别:
Operating Grants